Bill
Bill > HB746
MD HB746
MD HB746Maryland Medical Assistance Program – Gender–Affirming Treatment (Trans Health Equity Act of 2022)
summary
Introduced
02/03/2022
02/03/2022
In Committee
02/03/2022
02/03/2022
Crossed Over
Passed
Dead
04/11/2022
04/11/2022
Introduced Session
2022 Regular Session
Bill Summary
Requiring, beginning on January 1, 2023, the Maryland Medical Assistance Program to provide gender-affirming treatment; and prohibiting the Program from issuing an adverse benefit determination related to gender-affirming treatment unless a health care provider with experience prescribing or delivering gender-affirming treatment has reviewed and confirmed the appropriateness of the determination.
AI Summary
This bill, the "Trans Health Equity Act of 2022," requires the Maryland Medical Assistance Program to provide gender-affirming treatment starting January 1, 2023. Gender-affirming treatment includes a range of medically necessary services such as hormone therapy, hair alteration, voice modification, and surgical procedures to align an individual's appearance or physical body with their gender identity. The bill prohibits the program from denying or limiting coverage for gender-affirming treatment that is prescribed appropriately and medically necessary. It also requires managed care organizations to report annually on the providers offering these services, and for the state to publish a report on geographic access to gender-affirming care across Maryland.
Committee Categories
Health and Social Services
Sponsors (1)
Last Action
House Health and Government Operations Hearing (13:30 3/2/2022 ) (on 03/02/2022)
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://mgaleg.maryland.gov/mgawebsite/Legislation/Details/HB0746?ys=2022RS |
| Vote Image | https://mgaleg.maryland.gov/2022RS/votes_comm/hb0746_hgo.pdf |
| BillText | https://mgaleg.maryland.gov/2022RS/bills/hb/hb0746f.pdf |
Loading...